Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Designing vaccines based on biology of human dendritic cell subsets.

Palucka K, Banchereau J, Mellman I.

Immunity. 2010 Oct 29;33(4):464-78. doi: 10.1016/j.immuni.2010.10.007. Review.

2.

Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.

Shojaeian J, Jeddi-Tehrani M, Dokouhaki P, Mahmoudi AR, Ghods R, Bozorgmehr M, Nikoo S, Bayat AA, Akhondi MM, Ostadkarampour M, Rezania S, Zarnani AH.

J Immunother. 2009 May;32(4):325-32. doi: 10.1097/CJI.0b013e31819aa31e.

PMID:
19342973
3.

Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines.

Klechevsky E, Liu M, Morita R, Banchereau R, Thompson-Snipes L, Palucka AK, Ueno H, Banchereau J.

Hum Immunol. 2009 May;70(5):281-8. doi: 10.1016/j.humimm.2009.02.004. Epub 2009 Feb 21.

4.

Processing and presentation of antigens by dendritic cells: implications for vaccines.

Bhardwaj N.

Trends Mol Med. 2001 Sep;7(9):388-94. Review.

PMID:
11530333
5.
8.

[Dendritic cells of mucosa and skin: "recruited for vaccination"].

Le Borgne M, Dubois B, Kaiserlian D.

Med Sci (Paris). 2007 Oct;23(10):819-25. Review. French.

9.

Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.

Petersen TR, Sika-Paotonu D, Knight DA, Simkins HM, Hermans IF.

PLoS One. 2011 Mar 31;6(3):e17657. doi: 10.1371/journal.pone.0017657.

10.

Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.

Suleman M, Galea S, Gavard F, Merillon N, Klonjkowski B, Tartour E, Richardson J.

Vaccine. 2011 Aug 11;29(35):5892-903. doi: 10.1016/j.vaccine.2011.06.071. Epub 2011 Jul 1.

PMID:
21723900
11.

NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.

Shibolet O, Alper R, Zlotogarov L, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Int J Cancer. 2003 Aug 20;106(2):236-43.

12.

CD8α(-) Dendritic Cells Induce Antigen-Specific T Follicular Helper Cells Generating Efficient Humoral Immune Responses.

Shin C, Han JA, Koh H, Choi B, Cho Y, Jeong H, Ra JS, Sung PS, Shin EC, Ryu S, Do Y.

Cell Rep. 2015 Jun 30;11(12):1929-40. doi: 10.1016/j.celrep.2015.05.042. Epub 2015 Jun 18.

13.

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.

Fehres CM, Kalay H, Bruijns SC, Musaafir SA, Ambrosini M, van Bloois L, van Vliet SJ, Storm G, Garcia-Vallejo JJ, van Kooyk Y.

J Control Release. 2015 Apr 10;203:67-76. doi: 10.1016/j.jconrel.2015.01.040. Epub 2015 Feb 2.

PMID:
25656175
14.

Dendritic cell-based vaccines: barriers and opportunities.

Cintolo JA, Datta J, Mathew SJ, Czerniecki BJ.

Future Oncol. 2012 Oct;8(10):1273-99. doi: 10.2217/fon.12.125. Review.

15.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

16.

Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design.

Baz A, Jackson DC, Kienzle N, Kelso A.

Expert Rev Vaccines. 2005 Oct;4(5):711-23. Review.

PMID:
16221072
17.
18.
19.

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJ, Dunbar PR, Wadley RB, Jeet V, Vulink AJ, Hart DN, Radford KJ.

J Exp Med. 2010 Jun 7;207(6):1247-60. doi: 10.1084/jem.20092140. Epub 2010 May 17.

Supplemental Content

Support Center